Clinical Trial Update: ALC-919 For The Treatment Of Common Warts [Phase 2]

View source ↗

Summary

Phase 2 trial update showing completion of a study evaluating ALC-919 for the treatment of verruca vulgaris (common warts).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Verruca Vulgaris

Drugs mentioned

• ALC-919

Snippet

Sponsor: Veloce BioPharma LLC | Conditions: Verruca Vulgaris | Phase 2 | Status: COMPLETED